Hepatitis C Vaccine Preparedness Study: Investing in Infectious Disease Prevention

注射吸毒者（IDU）是预防丙型肝炎病毒（HCV）感染的新疫苗的关键目标群体。这项研究将通过回答关键的科学问题，生成数据以告知试验设计和评估，建立领先的国际研究人员与澳大利亚注射毒品者的最高机构之间的伙伴关系，并为全球HCV预防试验网络提供基础，来确定在注射吸毒者中进行HCV疫苗试验的可行性。

Injecting drug users (IDU) are a key target group for new vaccines designed to prevent hepatitis C virus (HCV) infection. This study will establish the feasibility of conducting HCV vaccine trials in IDUs by answering key scientific questions, generating data to inform trial design and evaluation, establishing a partnership between leading international researchers and the peak Australian body for people who inject drugs, and providing the foundation for a global HCV prevention trial network.